CARDIOPROGRESS
Foundation for the advancement of cardiology

Scotland Accepts New RNAi Therapy for Cardiac Amyloidosis The Scottish Medicines Consortium (SMC) has accepted vutrisiran sodium (Amvuttra, Alnylam UK Ltd) for restricted use in NHS Scotland as monotherapy in adults with wild-type or hereditary transthyretin amyloidosis with cardiomyopathy (ATTR-CM).

European experts have proposed new criteria for the diagnosis of cardiogenic shock The European Society of Cardiology has presented new criteria for the diagnosis of cardiogenic shock, which should help to identify the condition faster and unify approaches to its diagnosis. Experts suggest assessing at the same time the signs of impaired blood supply to organs, hemodynamic disorders and severe cardiac dysfunction.

Heart Failure Rewritten: What the 2026 ESC Guidelines Mean for Primary Care At the 2026 Congress of the European Society of Cardiology (ESC), updates to the guidelines on heart failure (HF) were presented.

A new global definition of myocardial infarction A new global definition of myocardial infarction has been devised by a task force of four major cardiology societies, with the goal of enabling cardiologists and other healthcare professionals to better diagnose and treat patients with the condition.

Most important clinical trials presented at the HOT LINE sessions of the European Society of Cardiology Congress 2026 The next Congress of the European Society of Cardiology was held in Munich (Germany) from August 28 to 31, 2026. The motto of this year's event is "Research. Innovation. Inspiration." The Congress participants reviewed 4 new texts of clinical recommendations in various fields of cardiology and other fields of medicine.

ACC and AHA updated their recommendations on statins in 2026 Cardiologists have revised the 2018 statin recommendations. After just under 10 years, during which the target indicators were based solely on percentage reduction, clear numerical target levels for low‑density lipoproteins have been re‑established.

New Tool to Guide Transcatheter Aortic Valve Replacement A new German trigger tool identified adverse events in pediatric cardiology admissions, with most events causing temporary harm. The tool demonstrated good interrater reliability and was feasible for systematic detection of patient harm in hospitalized children.

The release of a new open access journal of cardiology In August 2026, a group of cardiologists launched the peer—reviewed open access journal OpenSource: Cardiology. The main difference of the publication is the complete absence of publication fees for the authors.

To Beat Cigarette Addiction, Experts Embrace Vapes Clinicians can now recommend vapes, along with nicotine patches and gums, to their adult patients who want to quit smoking traditional cigarettes. The guidance, from a leading international group of tobacco researchers, represents a sharp pivot from an earlier stance that evolved as evidence mounted that vaping may be more effective in helping people quit cigarettes than traditional nicotine replacement therapies like varenicline or bupropion.

New Guidelines Expand Statin Eligibility to More Than Half of US Adults A new study has shown that the updated recommendations of the American Heart Association and the American College of Cardiology on dyslipidemia, published in March 2026, expand indications for statin therapy for primary prevention, now covering adults aged 30-79 years (instead of 40-75 years), assessing the risk for several decades ahead and using an updated risk calculator, which will allow such treatment to spread. 87.5 million adults in the United States.